Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (rsvpref3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial
JOURNAL OF INFECTIOUS DISEASES(2023)
Key words
AS01 adjuvant,RSV neutralizing antibodies,cell-mediated immunity,F protein,respiratory syncytial virus
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined